![](/img/cover-not-exists.png)
PAR3 COST-BENEFIT OF RITUXIMAB FOR RHEUMATOID ARTHRITIS PATIENTS IN ARGENTINA
JP Solé, GP Ortega, A KielhornVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)64918-2
File:
PDF, 91 KB
english, 2007